Capricor Therapeutics
CAPR
#7318
Rank
C$0.80 B
Marketcap
C$13.91
Share price
9.44%
Change (1 day)
78.11%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2023 (TTM): C-$1.58

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$3.46. In 2022 the company made an earnings per share (EPS) of C-$1.67 a decrease over its 2021 EPS that were of C-$1.23.

EPS history for Capricor Therapeutics from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$1.58-5.04%
2022C-$1.6735.63%
2021C-$1.23-7.45%
2020C-$1.33-55.45%
2019C-$2.98-59.81%
2018C-$7.41-1850%
2017C$0.42-102.94%
2016C-$14.4025.93%
2015C-$11.4455.77%
2014C-$7.34-39.53%
2013C-$12.14-64.78%
2012C-$34.47-62.44%
2011C-$91.77-31.58%
2010C-$134.13-38.71%
2009C-$218.84-43.64%
2008C-$388.27-5.17%
2007C-$409.45427.27%
2006C-$77.65340.33%
2005C-$17.64
2004N/A
2003N/A
2002N/A
2001N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.44-372.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$9.95-387.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C-$10.19 194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.14 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C-$10.66 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$41.35 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA